2020 ePoster – Transplantation

A WEIGHTMAN1,2, P CLAYTON1,2,3, S COGHLAN4 1University Of Adelaide, Adelaide, Australia, 2Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia, 3Central and Northern Adelaide Renal and Transplantation Service, Royal Adelaide...
  • 19 October 2020
Read More
Z THET1,2,6, A LAM1,  S NG1,  K RAZAK2,  D RANGANATHAN1,4,  S AUNG3,6,  T HAN2,6, J BORG2, C PEPITO2, S NEWSHAM2, T KHOO1,5 1School of Medicine, Griffith University, Brsibane/Goldcoast, Australia, 2Department of Nephrology, Central Queensland Hospital and Health Service, Rockhampton, Australia,...
  • 19 October 2020
Read More
U SURAPATI1, A NURANI1, D  PARTININGRUM1, A ARWANTO1,  L LESTARININGSIH1, S CHASANI1 1RSUP Dr. Kariadi /medical Faculty Universitas Diponegoro, Semarang, Indonesia Aim: To determine between the associated factors and early graft function (EGF) after living kidney donor transplantation. Background: Kidney...
  • 19 October 2020
Read More
T SALEHI1,  N MONTARELLO2,  A BATE2,  P CLAYTON1,  M WORTHLEY2, P COATES1 1Central Adelaide And Northern Renal And Transplantation Services, Adelaide, Australia, 2Department of Cardiology, Adelaide, Australia Background: Cardiovascular events remain a major cause of death in kidney transplant recipients. The...
  • 19 October 2020
Read More
T SALEHI1,  P CLAYTON2 1Central Adelaide And Northern Renal And Transplantation Services, Adelaide, Australia, 2The University of Adelaide, Adelaide, Australia Aim: To explore the impact of specific T cell suppressive agents on early outcomes post renal transplantation. Background: The optimal...
  • 19 October 2020
Read More
F REIMANN1,2, P GALETTIS1, J JOHNSTONE1, J SCHNEIDER1, P TREVILLIAN1,3, J MARTIN1,3 1School of Medicine and Public Health, University of Newcastle, Newcastle, Australia, 2Calvary Mater Hospital, Newcastle, Australia, 3John Hunter Hospital, Newcastle, Australia Background: Tacrolimus, ciclosporin, sirolimus and everolimus blood...
  • 19 October 2020
Read More
B PATEL1, A NEJATIAN1, L SKEAT2,  G KIRKLAND2,  M JOSE1,2 1School of Medicine, University of Tasmania, Launceston, Australia, 2Renal Unit, Royal Hobart Hospital, Launceston, Australia Aim: To review the diagnosis, management and outcomes of antibody-mediated rejection (AMR) in kidney transplant...
  • 19 October 2020
Read More
L MYAT1,  S MAY1 1Tamworth Hospital, Sydney, Australia Background: Diarrhea is a frequent complication in kidney transplant recipients, resulting in a significant increase in morbidity and a poorer graft outcome. Nitazoxanide (NTZ) is a thiazolide antimicrobial developed in the 1980s....
  • 19 October 2020
Read More
M MUKHERJEE1,  R LEU1,2,3,  C TRIMINGHAM2, N WATSON2,  S JESUDASON2,3,  P CLAYTON2, A MEADE2 1National Indigenous Kidney Transplantation Taskforce, South Australian Health and Medical Research Institute, Adelaide, Australia, 2Renal Home Therapies, Top End Health Service, Tiwi, Australia, 3Infectious Diseases Department,...
  • 19 October 2020
Read More
S MCDONALD1,  K DOLE2,  P BOAN3,4, W LIM5,6,  S CHERIAN7,8,  A ABEYARATNE9,10 1National Indigenous Kidney Transplantation Taskforce, South Australian Health and Medical Research Institute, Adelaide, Australia, 2Renal Home Therapies, Top End Health Service, Tiwi, Australia, 3Infectious Diseases Department, Fiona Stanley...
  • 19 October 2020
Read More
Categories